A sanitary tampon that includes a body of generally cylindrical shape provided with a rounded front end in the insertion direction of the tampon and with a rear end from which an extraction cord protrudes; the body including an absorbent core, rectangular, with two major sides and two minor sides, covered with an absorbent sheet of non-woven fabric, and wound in the longitudinal direction and pressed together with said absorbent sheet, its major sides being oriented towards the front and rear ends of the body of the tampon and the tampon being made entirely of natural materials.

A sanitary tampon that includes a body of generally cylindrical shape provided with a rounded front end in the insertion direction of the tampon and with a rear end from which an extraction cord protrudes; the body including an absorbent core, rectangular, with two major sides and two minor sides, covered with an absorbent sheet of non-woven fabric, and wound in the longitudinal direction and pressed together with said absorbent sheet, its major sides being oriented towards the front and rear ends of the body of the tampon and the tampon being made entirely of natural materials.

The disclosure relates to an absorbent undergarment comprising a fabric layer defining a waist opening, two leg openings and a crotch region between the leg openings, the absorbent undergarment further comprising an absorbent pad covering at least part of said crotch region and being permanently attached to the fabric layer. The absorbent pad comprises at least one absorbent layer and a skin-facing layer. At least one layer, selected from said absorbent layer, said skin-facing layer or an optionally present wicking layer, comprises naturally-derived fibers comprising a polycarboxylic acid. The polycarboxylic acid has at least one carboxyl group covalently bound to the naturally-derived fibers and at least one free carboxyl group.

The disclosure relates to an absorbent undergarment comprising a fabric layer defining a waist opening, two leg openings and a crotch region between the leg openings, the absorbent undergarment further comprising an absorbent pad covering at least part of said crotch region and being permanently attached to the fabric layer. The absorbent pad comprises at least one absorbent layer and a skin-facing layer. At least one layer, selected from said absorbent layer, said skin-facing layer or an optionally present wicking layer, comprises naturally-derived fibers comprising a polycarboxylic acid. The polycarboxylic acid has at least one carboxyl group covalently bound to the naturally-derived fibers and at least one free carboxyl group.

The invention relates to the use of a urease inhibitor in an absorbent article to maintain the pH of the wearer's skin in a range of 4.0 to 6.0, wherein the urease inhibitor is provided between the topsheet and the absorbent core and/or is provided in the absorbent core. The invention also relates to absorbent articles comprising a urease inhibitor.

The invention relates to the use of a urease inhibitor in an absorbent article to maintain the pH of the wearer's skin in a range of 4.0 to 6.0, wherein the urease inhibitor is provided between the topsheet and the absorbent core and/or is provided in the absorbent core. The invention also relates to absorbent articles comprising a urease inhibitor.

The present invention relates to a medical composition and a method for preparing the same, the medical composition comprising: an adipose tissue-derived extracellular matrix powder; and a biocompatible polymer or a crosslinked product of the biocompatible polymer. The medical composition according to the present invention exists in a well-aggregated state even after implantation in the body and can maintain the volume thereof for a certain time.

The present invention relates to a medical composition and a method for preparing the same, the medical composition comprising: an adipose tissue-derived extracellular matrix powder; and a biocompatible polymer or a crosslinked product of the biocompatible polymer. The medical composition according to the present invention exists in a well-aggregated state even after implantation in the body and can maintain the volume thereof for a certain time.

A system for managing female incontinence includes a body of biocompatible material configured to fit between the labia minora and the vestibule floor, the body having a surface configured to occlude the urethral meatus, an adhesive carried on at least a first portion of the surface and configured to provide a sealing engagement between the body and the urethral meatus, and a substance carried by at least one of the body and the adhesive and configured for controlling the odor of the general vaginal-urethral area of a female.

A system for managing female incontinence includes a body of biocompatible material configured to fit between the labia minora and the vestibule floor, the body having a surface configured to occlude the urethral meatus, an adhesive carried on at least a first portion of the surface and configured to provide a sealing engagement between the body and the urethral meatus, and a substance carried by at least one of the body and the adhesive and configured for controlling the odor of the general vaginal-urethral area of a female.